Five-year results of vocal fold augmentation using autologous fat or calcium hydroxylapatite

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F21%3AA220271K" target="_blank" >RIV/61988987:17110/21:A220271K - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00843989:_____/21:E0108927

Výsledek na webu

<a href="https://link.springer.com/article/10.1007/s00405-020-06479-6" target="_blank" >https://link.springer.com/article/10.1007/s00405-020-06479-6</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/s00405-020-06479-6" target="_blank" >10.1007/s00405-020-06479-6</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Five-year results of vocal fold augmentation using autologous fat or calcium hydroxylapatite

Popis výsledku v původním jazyce

Purpose To evaluate 5-year voice outcomes of vocal fold augmentation (VFA) using autologous fat (AF) injection via direct microlaryngoscopy versus office-based calcium hydroxylapatite (CaHA) injection. Methods Retrospective study of patients who underwent VFA between 2012 and 2015, with a 5-year follow-up. Patients with a glottic gap of <= 3 mm caused by unilateral vocal fold paralysis or vocal fold atrophy were included in the study. VFA was performed using AF injection via direct microlaryngoscopy in 17 patients, and using office-based CaHA injection in 19 patients. Subjective satisfaction with voice, voice handicap index (VHI), and maximal phonation time (MPT) were analyzed pre-injection, and at 12 and 60 months post-VFA. Results Altogether 36 patients underwent VFA between 2012 and 2015, of whom 5 were excluded within 1 year post-VFA, and 2 were excluded between 1 and 5 years post-VFA. Of the remaining 29 patients, 3 (10.3%) underwent re-intervention at between 1 and 3 years post-VFA. Thus, the 5-year follow-up included 26 patients (72.2%; 11 males and 15 females). At 5 years after surgery, 73.1% of the patients were satisfied with their voice, with no significant between-group difference (P = 0.307). The mean improvement of VHI was 28.8 +/- 17.82 in the autologous fat group versus 33 +/- 26.24 in the CaHA group (P = 0.458). MPT improvement was also similar between the two groups: 6.2 +/- 4.26 for the autologous fat group versus 6.3 +/- 4.34 for the CaHA group (P = 0.667). Conclusions Both AF injection via direct microlaryngoscopy and office-based CaHA injection yielded good and comparable 5-year results.

Název v anglickém jazyce

Five-year results of vocal fold augmentation using autologous fat or calcium hydroxylapatite

Popis výsledku anglicky

Purpose To evaluate 5-year voice outcomes of vocal fold augmentation (VFA) using autologous fat (AF) injection via direct microlaryngoscopy versus office-based calcium hydroxylapatite (CaHA) injection. Methods Retrospective study of patients who underwent VFA between 2012 and 2015, with a 5-year follow-up. Patients with a glottic gap of <= 3 mm caused by unilateral vocal fold paralysis or vocal fold atrophy were included in the study. VFA was performed using AF injection via direct microlaryngoscopy in 17 patients, and using office-based CaHA injection in 19 patients. Subjective satisfaction with voice, voice handicap index (VHI), and maximal phonation time (MPT) were analyzed pre-injection, and at 12 and 60 months post-VFA. Results Altogether 36 patients underwent VFA between 2012 and 2015, of whom 5 were excluded within 1 year post-VFA, and 2 were excluded between 1 and 5 years post-VFA. Of the remaining 29 patients, 3 (10.3%) underwent re-intervention at between 1 and 3 years post-VFA. Thus, the 5-year follow-up included 26 patients (72.2%; 11 males and 15 females). At 5 years after surgery, 73.1% of the patients were satisfied with their voice, with no significant between-group difference (P = 0.307). The mean improvement of VHI was 28.8 +/- 17.82 in the autologous fat group versus 33 +/- 26.24 in the CaHA group (P = 0.458). MPT improvement was also similar between the two groups: 6.2 +/- 4.26 for the autologous fat group versus 6.3 +/- 4.34 for the CaHA group (P = 0.667). Conclusions Both AF injection via direct microlaryngoscopy and office-based CaHA injection yielded good and comparable 5-year results.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30206 - Otorhinolaryngology

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2021

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

EUR ARCH OTO-RHINO-L

ISSN

0937-4477

e-ISSN

1434-4726

Svazek periodika

278

Číslo periodika v rámci svazku

4

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

6

Strana od-do

1139-1144

Kód UT WoS článku

000591988800003

EID výsledku v databázi Scopus

—